Effect of Age, Body Mass Index and Tumor Sidedness in Metastatic Colorectal Cancer

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

NCT06404593 ·Status: COMPLETED

Gastric Cancer Liver Metastasis Cohort of China

NCT04574245 ·Status: UNKNOWN

Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer

NCT06934018 ·Status: RECRUITING ·Phase: NA

Circulating Tumor Cells in mCRC for Liver Resection

NCT03295591 ·Status: UNKNOWN

Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras

NCT01651013 ·Status: UNKNOWN

Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer

NCT03936530 ·Status: ACTIVE_NOT_RECRUITING

Clinical Characteristics and Prognosis of Simultaneous Versus Delayed Resection for Synchronous Colorectal Liver Metastasis: A Nationwide Multicenter Study Utilizing Propensity Score Matching Analysis

NCT07082335 ·Status: COMPLETED

Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer

NCT05950503 ·Status: RECRUITING

Significance of Benign Lymph Node Enlargement in Colorectal Cancer

NCT06410729 ·Status: COMPLETED

Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.

NCT06929013 ·Status: RECRUITING ·Phase: NA

Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy

NCT04456283 ·Status: UNKNOWN

RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer

NCT02502656 ·Status: UNKNOWN

Perfusion and Diffusion Magnetic Resonance Imaging, and Phosphorylation of Circulation Endothelial Cells to Determine Anti-anogenic Effect of Chemotherapeutic Regimens in Colorectal Liver Metastasis Patients

NCT01318239 ·Status: COMPLETED ·Phase: NA

Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers

NCT00172159 ·Status: UNKNOWN ·Phase: PHASE2

Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

NCT01834014 ·Status: COMPLETED ·Phase: NA

Independent Risk Factors Analysis and Model Construction For Recurrence After Radiofrequency/Microwave Ablation of Colorectal Cancer With Liver Metastases: a Retrospective, Multicenter Trial

NCT05268549 ·Status: UNKNOWN

Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer

NCT02355353 ·Status: UNKNOWN ·Phase: NA

Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases

NCT02015923 ·Status: TERMINATED ·Phase: PHASE4

Metastatic Lymph Node Distribution in the Ileum Mesentery of Cecal and Proximal Ascending Colon Cancer

NCT07149623 ·Status: NOT_YET_RECRUITING

Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.

NCT02331641 ·Status: COMPLETED

Prognostic Significance of Lymph Node Ratio in Rectal Cancer on Overall Survival

NCT05667259 ·Status: COMPLETED

Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers

NCT00594529 ·Status: UNKNOWN ·Phase: PHASE2

Colorectal Cancer With Liver-limited Synchronous Metastases: an Inception Cohort Study of Standardised Care Pathways

NCT02456285 ·Status: COMPLETED

Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer

NCT05572151 ·Status: COMPLETED

Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective

NCT03935763 ·Status: ACTIVE_NOT_RECRUITING